A radiohybrid theranostics ligand labeled with fluorine-18 and lutetium-177 for fibroblast activation protein-targeted imaging and radionuclide therapy

PURPOSE: A series of radiotracers targeting fibroblast activation protein (FAP) with great pharmacokinetics have been developed for cancer diagnosis and therapy. Nevertheless, the use of dominant PET tracers, gallium-68–labeled FAPI derivatives, was limited by the short nuclide half-life and product...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Tianhong, Peng, Lei, Qiu, Jia, He, Xingjin, Zhang, Dake, Wu, Renbo, Liu, Jianbo, Zhang, Xiangsong, Zha, Zhihao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10250256/
https://www.ncbi.nlm.nih.gov/pubmed/36864362
http://dx.doi.org/10.1007/s00259-023-06169-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10250256/
https://www.ncbi.nlm.nih.gov/pubmed/36864362
http://dx.doi.org/10.1007/s00259-023-06169-5

Ejemplares similares